Lifestance Health Group Stock Fundamentals

LFST Stock  USD 7.09  0.22  3.01%   
As of the 27th of January, Lifestance Health secures the Mean Deviation of 1.65, downside deviation of 1.58, and Risk Adjusted Performance of 0.116. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lifestance Health, as well as the relationship between them.

Lifestance Health Total Revenue

810.96 Million

Analyzing historical trends in various income statement and balance sheet accounts from Lifestance Health's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Lifestance Health's valuation are summarized below:
Gross Profit
444.2 M
Profit Margin
(0.01)
Market Capitalization
2.8 B
Enterprise Value Revenue
2.2758
Revenue
1.4 B
There are currently one hundred twenty fundamental ratios for Lifestance Health that can be evaluated and compared over time across peers in the industry. All traders should check Lifestance Health's last-minute fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to drop to about 2.3 B in 2026 This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
At this time, Lifestance Health's Selling And Marketing Expenses is comparatively stable compared to the past year. EBITDA is likely to gain to about 37.7 M in 2026, whereas Tax Provision is likely to drop (160.7 K) in 2026.
  
Build AI portfolio with Lifestance Stock

Lifestance Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.9 B2.4 BB
Slightly volatile
Short and Long Term Debt Total381.2 M558 M219.6 M
Slightly volatile
Other Current Liabilities97.6 M189.7 M72.8 M
Slightly volatile
Total Current Liabilities156.8 M263.2 M104.2 M
Slightly volatile
Other Liabilities70.9 M47.7 M32.3 M
Slightly volatile
Property Plant And Equipment Net238.4 M361 M123.6 M
Slightly volatile
Net Debt287 M380.2 M171.5 M
Slightly volatile
Accounts Payable15.6 M8.3 M10.8 M
Slightly volatile
Cash93.9 M177.8 M48 M
Slightly volatile
Non Current Assets Total1.7 B2.1 B885.4 M
Slightly volatile
Non Currrent Assets Other6.8 M8.9 M3.8 M
Slightly volatile
Other Assets3.8 M7.3 M2.9 M
Slightly volatile
Long Term Debt253.8 M321.8 M157.3 M
Slightly volatile
Cash And Short Term Investments93.9 M177.8 M48 M
Slightly volatile
Net Receivables91.3 M151.8 M53.7 M
Slightly volatile
Good Will1.2 B1.5 B645 M
Slightly volatile
Common Stock Total Equity3.2 M3.4 M60.7 M
Pretty Stable
Common Stock Shares Outstanding399.1 M436 M375 M
Pretty Stable
Liabilities And Stockholders Equity1.9 B2.4 BB
Slightly volatile
Non Current Liabilities Total468.2 M509.6 M415.3 M
Slightly volatile
Inventory1.091.153.4 M
Very volatile
Other Current Assets17.1 M29.8 M10.8 M
Slightly volatile
Other Stockholder Equity1.5 B2.6 B739.5 M
Slightly volatile
Total Liabilities625 M772.8 M519.5 M
Slightly volatile
Property Plant And Equipment Gross271.5 M467.2 M142.4 M
Slightly volatile
Total Current Assets209.3 M359.4 M115.1 M
Slightly volatile
Capital Stock3.3 M3.4 M60.7 M
Pretty Stable
Non Current Liabilities Other337.6 K355.4 K22.3 M
Pretty Stable
Short Term Debt68.5 M65.2 M17.3 M
Slightly volatile
Intangible Assets242.6 M219.4 M112.9 M
Slightly volatile
Common Stock3.3 M3.4 M60.7 M
Pretty Stable
Property Plant Equipment117.8 M223.3 M80 M
Slightly volatile
Short and Long Term Debt8.8 M8.3 M4.2 M
Slightly volatile
Long Term Debt Total210.4 M258.8 M178.4 M
Slightly volatile
Capital Surpluse2.2 B2.4 BB
Slightly volatile
Deferred Long Term Liabilities37.2 M34.8 M49.4 M
Slightly volatile

Lifestance Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization57.2 M81.6 M29.7 M
Slightly volatile
Interest Expense24.6 M30.5 M14 M
Slightly volatile
Selling General Administrative314.3 M417.5 M165.6 M
Slightly volatile
Selling And Marketing Expenses3.4 M2.1 M1.7 M
Slightly volatile
Total Revenue811 M1.4 B505 M
Slightly volatile
Gross Profit245.6 M462.8 M153.5 M
Slightly volatile
Other Operating Expenses936.8 M1.5 B546.9 M
Slightly volatile
Cost Of Revenue565.3 M975.9 M351.5 M
Slightly volatile
Total Operating Expenses371.5 M499.1 M195.4 M
Slightly volatile
Reconciled Depreciation61 M81.6 M31.1 M
Slightly volatile

Lifestance Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation114.4 M87.6 M48.6 M
Slightly volatile
Begin Period Cash Flow67.7 M90.6 M37 M
Slightly volatile
Depreciation57.2 M81.6 M29.7 M
Slightly volatile
Capital Expenditures23.6 M24.8 M27.4 M
Slightly volatile
End Period Cash Flow93.9 M177.8 M48 M
Slightly volatile
Change To Liabilities25.7 M24.5 M8.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.442.5724.9071
Slightly volatile
Days Sales Outstanding33.9434.6736.4017
Slightly volatile
Stock Based Compensation To Revenue0.10.05480.0543
Slightly volatile
Capex To Depreciation0.330.351.7111
Slightly volatile
EV To Sales2.732.8725.2718
Slightly volatile
Inventory Turnover9.7911.0212.0244
Slightly volatile
Days Of Inventory On Hand23.8626.8429.2936
Slightly volatile
Payables Turnover11110537.4622
Slightly volatile
Sales General And Administrative To Revenue0.30.260.2643
Slightly volatile
Capex To Revenue0.01880.01980.0648
Slightly volatile
Cash Per Share0.190.370.1226
Slightly volatile
Days Payables Outstanding3.43.5815.2922
Slightly volatile
Intangibles To Total Assets0.850.810.8032
Slightly volatile
Current Ratio1.011.230.8421
Slightly volatile
Receivables Turnover9.6810.910.1982
Slightly volatile
Capex Per Share0.04860.05120.0743
Slightly volatile
Revenue Per Share1.622.971.2892
Slightly volatile
Interest Debt Per Share0.811.210.596
Slightly volatile
Debt To Assets0.230.260.2542
Slightly volatile
Operating Cycle52.1344.339.7922
Slightly volatile
Days Of Payables Outstanding3.43.5815.2922
Slightly volatile
Effective Tax Rate0.00320.00340.1884
Slightly volatile
Quick Ratio0.971.230.8206
Slightly volatile
Net Income Per E B T0.710.90.789
Slightly volatile
Cash Ratio0.430.610.2865
Slightly volatile
Cash Conversion Cycle28.3831.8722.7823
Slightly volatile
Days Of Inventory Outstanding23.8626.8429.2936
Slightly volatile
Days Of Sales Outstanding33.9434.6736.4017
Slightly volatile
Fixed Asset Turnover5.384.587.3279
Slightly volatile
Debt Ratio0.230.260.2542
Slightly volatile
Price Sales Ratio2.442.5724.9071
Slightly volatile
Asset Turnover0.520.680.6378
Slightly volatile
Gross Profit Margin0.340.370.3052
Slightly volatile

Lifestance Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.9 BB5.9 B
Slightly volatile
Enterprise Value2.3 B2.4 B6.1 B
Slightly volatile

Lifestance Fundamental Market Drivers

Forward Price Earnings53.1915
Cash And Short Term Investments154.6 M

Lifestance Upcoming Events

13th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Lifestance Return On Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Lifestance Health is extremely important. It helps to project a fair market value of Lifestance Stock properly, considering its historical fundamentals such as Return On Asset. Since Lifestance Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Lifestance Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Lifestance Health's interrelated accounts and indicators.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lifestance Health. If investors know Lifestance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lifestance Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.03)
Revenue Per Share
3.558
Quarterly Revenue Growth
0.163
Return On Assets
0.0026
Return On Equity
(0.01)
The market value of Lifestance Health is measured differently than its book value, which is the value of Lifestance that is recorded on the company's balance sheet. Investors also form their own opinion of Lifestance Health's value that differs from its market value or its book value, called intrinsic value, which is Lifestance Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lifestance Health's market value can be influenced by many factors that don't directly affect Lifestance Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lifestance Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifestance Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifestance Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Lifestance Health 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lifestance Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lifestance Health.
0.00
10/29/2025
No Change 0.00  0.0 
In 3 months and 1 day
01/27/2026
0.00
If you would invest  0.00  in Lifestance Health on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Lifestance Health Group or generate 0.0% return on investment in Lifestance Health over 90 days. Lifestance Health is related to or competes with Acadia Healthcare, National HealthCare, Aveanna Healthcare, Mednax, Ardent Health, Select Medical, and Astrana Health. LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services More

Lifestance Health Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lifestance Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lifestance Health Group upside and downside potential and time the market with a certain degree of confidence.

Lifestance Health Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Lifestance Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lifestance Health's standard deviation. In reality, there are many statistical measures that can use Lifestance Health historical prices to predict the future Lifestance Health's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lifestance Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
3.327.4211.52
Details
Intrinsic
Valuation
LowRealHigh
4.338.4312.53
Details
Naive
Forecast
LowNextHigh
3.237.3311.42
Details
8 Analysts
Consensus
LowTargetHigh
8.098.899.87
Details

Lifestance Health January 27, 2026 Technical Indicators

Lifestance Health Backtested Returns

Lifestance Health appears to be slightly risky, given 3 months investment horizon. Lifestance Health has Sharpe Ratio of 0.17, which conveys that the firm had a 0.17 % return per unit of risk over the last 3 months. By analyzing Lifestance Health's technical indicators, you can evaluate if the expected return of 0.7% is justified by implied risk. Please exercise Lifestance Health's Risk Adjusted Performance of 0.116, mean deviation of 1.65, and Downside Deviation of 1.58 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Lifestance Health holds a performance score of 13. The company secures a Beta (Market Risk) of 0.17, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Lifestance Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Lifestance Health is expected to be smaller as well. Please check Lifestance Health's semi variance, and the relationship between the sortino ratio and rate of daily change , to make a quick decision on whether Lifestance Health's current price movements will revert.

Auto-correlation

    
  0.66  

Good predictability

Lifestance Health Group has good predictability. Overlapping area represents the amount of predictability between Lifestance Health time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lifestance Health price movement. The serial correlation of 0.66 indicates that around 66.0% of current Lifestance Health price fluctuation can be explain by its past prices.
Correlation Coefficient0.66
Spearman Rank Test0.52
Residual Average0.0
Price Variance0.03
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Lifestance Total Assets

Total Assets

1.87 Billion

At this time, Lifestance Health's Total Assets are comparatively stable compared to the past year.
Based on the latest financial disclosure, Lifestance Health Group has a Return On Asset of 0.0026. This is 100.03% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 101.86% lower than that of the firm.

Lifestance Health Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Lifestance Health's current stock value. Our valuation model uses many indicators to compare Lifestance Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lifestance Health competition to find correlations between indicators driving Lifestance Health's intrinsic value. More Info.
Lifestance Health Group is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Lifestance Health's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Lifestance Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Lifestance Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lifestance Health's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lifestance Health could also be used in its relative valuation, which is a method of valuing Lifestance Health by comparing valuation metrics of similar companies.
Lifestance Health is currently under evaluation in return on asset category among its peers.

Lifestance Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Lifestance Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Lifestance Health's managers, analysts, and investors.
Environmental
Governance
Social

Lifestance Fundamentals

About Lifestance Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Lifestance Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lifestance Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lifestance Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue98 M102.9 M
Total Revenue1.4 B811 M
Cost Of Revenue975.9 M565.3 M
Stock Based Compensation To Revenue 0.05  0.10 
Sales General And Administrative To Revenue 0.26  0.30 
Capex To Revenue 0.02  0.02 
Revenue Per Share 2.97  1.62 
Ebit Per Revenue(0.03)(0.03)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Lifestance Stock Analysis

When running Lifestance Health's price analysis, check to measure Lifestance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifestance Health is operating at the current time. Most of Lifestance Health's value examination focuses on studying past and present price action to predict the probability of Lifestance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifestance Health's price. Additionally, you may evaluate how the addition of Lifestance Health to your portfolios can decrease your overall portfolio volatility.